Efficacy of live attenuated vaccines after two doses of intravenous immunoglobulin for Kawasaki disease

World J Pediatr. 2022 Oct;18(10):706-709. doi: 10.1007/s12519-022-00594-6. Epub 2022 Aug 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Mucocutaneous Lymph Node Syndrome* / drug therapy
  • Vaccines, Attenuated / therapeutic use

Substances

  • Immunoglobulins, Intravenous
  • Vaccines, Attenuated